Inventor · disambiguated record
Kevin Richard Guertin
Also filed as: GUERTIN KEVIN · GUERTIN KEVIN R · GUERTIN KEVIN RICHARD
16 granted patents·4 pending applications·253 citations·filing 1997–2021
92Inventor score
Files withHOFFMANN LA ROCHE9AVENTIS PHARM PROD INC4GENZYME CORP2AVENTIS PHARMA INC1BILOTTA JOSEPH A1
Top patents by PatentIndex Score
20 records- 0193US6323227B1Substituted N-[(aminoiminomethyl or aminomethyl)phenyl]propyl amidesAVENTIS PHARM PROD INC·Filed 1999·Granted Nov 27, 2001·76 cites·61 claims
- 0290US6080767ASubstituted n-[(aminoiminomethyl or aminomethyl)phenyl]propyl amidesAVENTIS PHARM PROD INC·Filed 1997·Granted Jun 27, 2000·100 cites·43 claims
- 0387US7947692B2Substituted thiazolo[5,4-d]pyrimidine urea derivativesHOFFMANN LA ROCHE·Filed 2007·Granted May 24, 2011·17 cites·41 claims
- 0484US7728029B2Adamantyl-pyrazole carboxamides as inhibitors of 11β-hdroxysteroid dehydrogenaseHOFFMANN LA ROCHE·Filed 2007·Granted Jun 1, 2010·8 cites·19 claims
- 0584US6482951B2Isoindolin-1-one glucokinase activatorsHOFFMANN LA ROCHE·Filed 2001·Granted Nov 19, 2002·23 cites·97 claims
- 0675US8188098B2GPR119 receptor agonistsERICKSON SHAWN DAVID·Filed 2009·Granted May 29, 2012·5 cites·2 claims
- 0775US7132425B25-substituted-six-membered heteroaromatic glucokinase activatorsHOFFMANN LA ROCHE·Filed 2003·Granted Nov 7, 2006·9 cites·93 claims
- 0874US7138529B2Substituted 3-cyanothiophene acetamides as glucagon receptor antagonistsHOFFMANN LA ROCHE·Filed 2004·Granted Nov 21, 2006·7 cites·36 claims
- 0964US6642381B2Pyrimido[5,4-e][1,2,4]triazine-5,7-diamine compounds as protein tyrosine phosphatase inhibitorsHOFFMANN LA ROCHE·Filed 2002·Granted Nov 4, 2003·2 cites·17 claims
- 1064US6140504ASubstituted intermediate compounds for the preparation of n-[(aminoiminomethyl or aminomethyl)phenyl]propyl amidesAVENTIS PHARM PROD INC·Filed 2000·Granted Oct 31, 2000·2 cites·2 claims
- 1159US8501732B2Aminomethyl quinolone compoundsBILOTTA JOSEPH A·Filed 2012·Granted Aug 6, 2013·1 cites·15 claims
- 1253US2023348454A1Compounds as modulators of bis-phosphoglycerate mutase for the treatment of sickle cell diseaseGENZYME CORP·Filed 2021·Application pending·0 cites
- 1353US2023348450A1Carboxylic acid-containing compounds as modulators of bis-phosphoglycerate mutase for the treatment of sickle cell diseaseGENZYME CORP·Filed 2021·Application pending·0 cites
- 1451US7790711B2Inhibitors of 11β-Hydroxysteroid DehydrogenaseHOFFMANN LA ROCHE·Filed 2008·Granted Sep 7, 2010·0 cites·15 claims
- 1548US2004067988A1Piperididinyl and N-amidinopiperidinyl derivativesAVENTIS PHARMA INC·Filed 2003·Application pending·0 cites
- 1644US2002016339A1Piperididinyl and N-amidinopiperidinyl derivativesFiled 2001·Application pending·0 cites
- 1743US7622492B2Pyrazolones as inhibitors of 11β-hydroxysteroid dehydrogenaseHOFFMANN LA ROCHE·Filed 2006·Granted Nov 24, 2009·0 cites·22 claims
- 1843US7407977B2Substituted N-acyl-2-aminothiazolesHOFFMANN LA ROCHE·Filed 2005·Granted Aug 5, 2008·0 cites·9 claims
- 1936US6277865B1Piperididinyl and N-amidinopiperidinyl derivativesAVENTIS PHARM PROD INC·Filed 1999·Granted Aug 21, 2001·3 cites·39 claims
- 2035US8471027B2Adamantyl compoundsCHEUNG ADRIAN WAI-HING·Filed 2012·Granted Jun 25, 2013·0 cites·15 claims
Join the waitlist — get patent alerts
Get an alert when Kevin Richard Guertin files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →